Bragar Eagel & Squire Files Class Action Against Elanco Animal Health Incorporated for Securities Fraud.

Bragar Eagel & Squire, P.C. announces the filing of a class action lawsuit against Elanco Animal Health Incorporated (“Elanco”) in the United States District Court for the District of Maryland. The lawsuit represents individuals and entities who purchased or acquired Elanco securities between November 7, 2023, and June 26, 2024 (the “Class Period”). Investors are reminded that the deadline to apply for lead plaintiff status in this case is December 6, 2024.

The Complaint asserts that during the Class Period, the Defendants issued materially false and misleading statements concerning the Company’s business, operations, and future prospects.

In particular, the Complaint contends that the Defendants either made false and/or misleading statements or failed to disclose critical information, including: (1) Zenrelia was not as safe as the Company had represented to investors; (2) Elanco was unlikely to adhere to its previously announced timeline for obtaining U.S. approval and launching both Zenrelia and Credelio Quattro; (3) consequently, the Company’s business and financial outlooks were exaggerated; and (4) as a result, the Company’s public statements were materially false and misleading throughout the relevant period.

If you acquired Elanco shares and suffered a loss, or have inquiries, contact Brandon Walker or Marion Passmore at [email protected], (212) 355-4648, or via our contact form. No cost or obligation.

Bragar Eagel & Squire, P.C. is and international law firm, headquartered in New York, United States. The firm specialize in commercial and securities litigation, including shareholders’ rights, federal securities claims,  bankruptcies, consumer protection and insolvency-related litigation.

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against WM Technology, Inc.